Autopsy report · NCT02479880
Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection
Cause of deathNo reason given
Life of this trial
- Ran for about 2 years 9 months before it stopped.
- 30 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Gilead Sciences
- Sponsor type
- Industry
- Conditions
- Hepatitis B
- Interventions
- Tenofovir DF; DEXA Scan
- Participants
- 30
- Sites
- 11
- Countries
- Belgium, France, Greece, Italy, Romania, Spain, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.